Moderna has accused the FDA of moving the goal posts and being inconsistent with earlier advice. The FDA has refused to accept Moderna's marketing application of an mRNA-based seasonal influenza ...
Casa pequena e moderna de 80 metros quadrados une conforto, funcionalidade e baixo custo construtivo
O projeto Casa Pequena e Moderna de 80m² representa uma solução equilibrada entre estilo, funcionalidade e conforto, adequada ...
A Casa de Campo Pequena e Moderna, localizada em áreas rurais próximas a cidades como Gramado e Campos do Jordão, ...
TudoGostoso on MSN
Diga adeus à sua varanda sem graça: 5 ideias modernas para decorá-la e fazê-la parecer maior
A varanda é um ambiente da casa cheio de possibilidades. Se você não vê muito potencial na sua por ser pequena, saiba que com escolhas inteligentes, esse espaço também pode virar um lugar interessante ...
The Food and Drug Administration has refused to review Moderna's application for its seasonal flu vaccine, the company announced on Feb. 10, marking the latest setback for the development of ...
WASHINGTON—In an hour-long meeting in January, Food and Drug Administration career staff laid out their objections to a plan to block a new flu shot from vaccine maker Moderna. They argued that ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
The Food and Drug Administration refused to review Moderna’s application for its new mRNA flu vaccine — a move the pharma giant’s’s president Dr. Stephen Hoge said left him in “complete shock.” In an ...
Federal officials on Wednesday cast blame on Moderna as they stood by the Food and Drug Administration’s controversial decision not to review the Cambridge biotech’s new flu vaccine. In a press ...
The U.S. Food and Drug Administration is refusing to consider Moderna’s application for a new flu vaccine made with Nobel Prize-winning mRNA technology, the company announced Tuesday. The news is the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results